Brief: Allurion Technologies Inc - Sees Growing Demand From Patients Discontinuing Glp-1 Therapy
20/04/2026 13:37
Allurion Technologies Inc ALUR.PK: ALLURION TECHNOLOGIES INC - SEES GROWING DEMAND FROM PATIENTS DISCONTINUING GLP-1 THERAPY ALLURION TECHNOLOGIES INC - EXPLORING PARTNERSHIPS WITH SELF-INSURED EMPLOYERS Source text: ID:nBw5VFqLna Further company coverage: ALUR.PK
Recent news on Allurion Technologies
See all newsBrief: Allurion Technologies Inc - Sees Growing Demand From Patients Discontinuing Glp-1 Therapy
Brief: Allurion Intends To Appeal NYSE Notice Of Delisting, Execute Plan To Regain Compliance, And Expects To Continue Trading On NYSE
Brief: NYSE To Commence Delisting Proceedings Against Allurion Technologies, Inc.
Allurion rises on plan to offer discounted weight-loss drug Mounjaro in Argentina
Allurion rises after strong weight-loss data from combination therapy